School of Medicine OIA request for Formal training on CB1, CB2 receptors and effects.

Shane Le Brun made this Official Information request to University of Auckland

The request was successful.

From: Shane Le Brun

Dear University of Auckland,
I would like to request information on what, if anything is
taught at Medical school on the Cannabinoid receptors, CB1, CB2,
and the effects of drugs, formulated or otherwise, on these
receptors and the various therapeutic responses.

I ask this question as the only CB1, CB2 targeting drug in NZ,
Sativex, a refined cannabis based preparation, has little known about it, and in Nelson in particular, 3 specialists, 1 Pain medicine, 2 Anaesthetists, know nothing about
it and refuse to prescribe it due to lack of knowledge, meaning
those who should qualify for it to alleviate their suffering are
still finding it unobtainable.

Within the Medicinal Cannabis Community in NZ it has also been observed that a disproportionate amount of foreign trained doctors are prescribing Sativex, compared
to NZ trained specialists.

It is also pertinent to the concept of future proofing our medical
training in NZ, as more formulated Cannabis based medicines become
available, and the wave of Cannabis law reform based around medical
use has arrived in Australia, meaning any medical professionals
working overseas are increasingly likely to be exposed to Medicinal
Cannabis going forwards.

Yours faithfully,

Shane Le Brun

Link to this

From: University of Auckland - Student Information Services
University of Auckland

[1]University of Auckland

Thank you for your enquiry. Our normal business hours are Monday to Friday
8am to 6pm. We aim to respond to your enquiry within two working days.
Subject [studentinfo] Official Information Act request - School of
Medicine OIA request forFormal training on CB1, CB2 receptors and effects.
Please keep a note of your Service Request reference number 150122-001794
in case you need to follow it up.
You can find additional answers to frequently asked questions on
[2]AskAuckland (www.askauckland.ac.nz).

[3]Copyright © The University of Auckland | [4]Privacy
[---001:000461:46808---]

References

Visible links
1. https://uoa.custhelp.com/#uoamap
2. http://www.askauckland.ac.nz/
3. Copyright © The University of Auckland
http://www.auckland.ac.nz/uoa/home/copyr...
4. Privacy
http://www.auckland.ac.nz/uoa/home/privacy

Link to this

From: University of Auckland - Student Information Services
University of Auckland

[1]Image

This message is from the University of Auckland.

Subject [studentinfo] Official Information Act request - School of
Medicine OIA request forFormal training on CB1, CB2 receptors and effects.

Administrator Auto-Response by 30/01/2015 11.22 AM
Service Request Updated
Administrator Response by 30/01/2015 11.22 AM
This is outside my expertise, Michelle Glass or Nick Holford may be able
to assist,
Regards
Susannah O'Sullivan

Customer by CSS Email 22/01/2015 12.43 PM
Dear University of Auckland,
I would like to request information on what, if anything is
taught at Medical school on the Cannabinoid receptors, CB1, CB2,
and the effects of drugs, formulated or otherwise, on these
receptors and the various therapeutic responses.

I ask this question as the only CB1, CB2 targeting drug in NZ,
Sativex, a refined cannabis based preparation, has little known about it,
and in Nelson in particular, 3 specialists, 1 Pain medicine, 2
Anaesthetists, know nothing about
it and refuse to prescribe it due to lack of knowledge, meaning
those who should qualify for it to alleviate their suffering are
still finding it unobtainable.

Within the Medicinal Cannabis Community in NZ it has also been observed
that a disproportionate amount of foreign trained doctors are prescribing
Sativex, compared
to NZ trained specialists.

It is also pertinent to the concept of future proofing our medical
training in NZ, as more formulated Cannabis based medicines become
available, and the wave of Cannabis law reform based around medical
use has arrived in Australia, meaning any medical professionals
working overseas are increasingly likely to be exposed to Medicinal
Cannabis going forwards.

Yours faithfully,

Shane Le Brun

-------------------------------------------------------------------

This is an OIA request done via the FYI website.

Please do not send progress updates as PDF files.

Disclaimer: This message and any reply that you make will be published on
the internet. Our privacy and copyright policies:
[2]https://fyi.org.nz/help/officers

If you find this service useful as an OIA officer, please ask your web
manager to link to us from your organisation's OIA page.

-------------------------------------------------------------------

[3]Copyright © The University of Auckland | [4]Privacy
[---001:001937:58775---]

References

Visible links
2. https://fyi.org.nz/help/officers
3. Copyright © The University of Auckland
http://www.auckland.ac.nz/uoa/home/copyr...
4. Privacy
http://www.auckland.ac.nz/uoa/home/privacy

Link to this

From: University of Auckland - Student Information Services
University of Auckland

[1]Image

This message is from the University of Auckland.

Subject [studentinfo] Official Information Act request - School of
Medicine OIA request forFormal training on CB1, CB2 receptors and effects.

Administrator Auto-Response by 05/02/2015 12.11 PM
Service Request Updated
Administrator Response by 05/02/2015 12.11 PM
I have reviewed teaching in the Department of Pharmacology & Clinical
Pharmacology with Faculty in the Department (A/Prof Michelle Glass and
Prof Mike Dragunow) who are involved with teaching that might involve
cannabinoid receptors and therapeutic use.

Cannabinoid receptors are taught as examples of G-protein coupled
receptors (year 2 medical students).
The use of cannaboids to treat symptoms of spasticity in a placebo
controlled trial in patients with multiple sclerosis is used to illustrate
the challenges of interpreting placebo controlled trials (year 2 medical
students).
We consider teaching about the specific use of Sativex in New Zealand to
be the domain of clinical specialists managing patients with multiple
sclerosis. It is not taught by the Department of Pharmacology & Clinical
Pharmacology.

Administrator Auto-Response by 30/01/2015 11.22 AM
Service Request Updated
Administrator Response by 30/01/2015 11.22 AM
This is outside my expertise, Michelle Glass or Nick Holford may be able
to assist,
Regards
Susannah O'Sullivan

Customer by CSS Email 22/01/2015 12.43 PM
Dear University of Auckland,
I would like to request information on what, if anything is
taught at Medical school on the Cannabinoid receptors, CB1, CB2,
and the effects of drugs, formulated or otherwise, on these
receptors and the various therapeutic responses.

I ask this question as the only CB1, CB2 targeting drug in NZ,
Sativex, a refined cannabis based preparation, has little known about it,
and in Nelson in particular, 3 specialists, 1 Pain medicine, 2
Anaesthetists, know nothing about
it and refuse to prescribe it due to lack of knowledge, meaning
those who should qualify for it to alleviate their suffering are
still finding it unobtainable.

Within the Medicinal Cannabis Community in NZ it has also been observed
that a disproportionate amount of foreign trained doctors are prescribing
Sativex, compared
to NZ trained specialists.

It is also pertinent to the concept of future proofing our medical
training in NZ, as more formulated Cannabis based medicines become
available, and the wave of Cannabis law reform based around medical
use has arrived in Australia, meaning any medical professionals
working overseas are increasingly likely to be exposed to Medicinal
Cannabis going forwards.

Yours faithfully,

Shane Le Brun

-------------------------------------------------------------------

This is an OIA request done via the FYI website.

Please do not send progress updates as PDF files.

Disclaimer: This message and any reply that you make will be published on
the internet. Our privacy and copyright policies:
[2]https://fyi.org.nz/help/officers

If you find this service useful as an OIA officer, please ask your web
manager to link to us from your organisation's OIA page.

-------------------------------------------------------------------

[3]Copyright © The University of Auckland | [4]Privacy
[---001:002733:09359---]

References

Visible links
2. https://fyi.org.nz/help/officers
3. Copyright © The University of Auckland
http://www.auckland.ac.nz/uoa/home/copyr...
4. Privacy
http://www.auckland.ac.nz/uoa/home/privacy

Link to this

Things to do with this request

Anyone:
University of Auckland only: